ABILIFY

Swiss trademark · 503917 · Word mark · In force

Register entry

Registration number
503917
Application number
07195/2002
Status
In force
Type
Word mark
Filed
Aug 20, 2002
Registered
Oct 9, 2002
Published
Oct 23, 2002
Protected until
Aug 20, 2032
Priority
13.06.2002 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung und Vorbeugung von Herz- und Gefässkrankheiten, Krankheiten und Störungen des Zentralnervensystems, Schlaganfall, Krebs, Entzündungs- und entzündlichen Krankheiten, Atmungs- und Infektionskrankheiten, Autoimmunkrankheiten, Antibiotika.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 27, 2022

    Agent removed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)

    Published in Swissreg on 27.07.2022

  2. Jul 27, 2022

    Agent entered

    Representative
    RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 27.07.2022

  3. Jul 27, 2022

    Renewed

    Published in Swissreg on 27.07.2022

  4. Jul 4, 2012

    Renewed

    Published in Swissreg on 04.07.2012

  5. Apr 10, 2007

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York (NY 10154), USA → Otsuka Pharmaceutical Co., Ltd., 2-9 Kanda Tsukasa-cho,, Chiyoda-ku, Tokyo 101-8535, Japan
    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 68 of 10.04.2007

  6. Oct 23, 2002

    Registered

    Published in the SOGC no. 205 of 23.10.2002

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.